ID   AMHR2_HUMAN             Reviewed;         573 AA.
AC   Q16671; A0AVE1; B9EGB7; Q13762;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-NOV-2010, entry version 112.
DE   RecName: Full=Anti-Muellerian hormone type-2 receptor;
DE            EC=2.7.11.30;
DE   AltName: Full=Anti-Muellerian hormone type II receptor;
DE            Short=AMH type II receptor;
DE   AltName: Full=MIS type II receptor;
DE            Short=MISRII;
DE            Short=MRII;
DE   Flags: Precursor;
GN   Name=AMHR2; Synonyms=AMHR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=96083584; PubMed=7493017; DOI=10.1038/ng1295-382;
RA   Imbeaud S., Faure E., Lamarre I., Mattei M.-G., di Clemente N.,
RA   Tizard R., Carre-Eusebe D., Belville C., Tragethon L., Tonkin C.,
RA   Nelson J., McAuliffe M., Bidart J.-M., Lababidi A., Josso N.,
RA   Cate R.L., Picard J.-Y.;
RT   "Insensitivity to anti-Muellerian hormone due to a mutation in the
RT   human anti-Muellerian hormone receptor.";
RL   Nat. Genet. 11:382-388(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=96028015; PubMed=7488027; DOI=10.1006/bbrc.1995.2567;
RA   Visser J.A., McLuskey A., van Beers T., Weghuis D.O., van Kessel A.G.,
RA   Grootegoed J.A., Themmen A.P.N.;
RT   "Structure and chromosomal localization of the human anti-Muellerian
RT   hormone type II receptor gene.";
RL   Biochem. Biophys. Res. Commun. 215:1029-1036(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   MEDLINE=20055680; PubMed=10589763;
RA   Masiakos P.T., MacLaughlin D.T., Maheswaran S., Teixeira J.,
RA   Fuller A.F. Jr., Shah P.C., Kehas D.J., Kenneally M.K.,
RA   Dombkowski D.M., Ha T.U., Preffer F.I., Donahoe P.K.;
RT   "Human ovarian cancer, cell lines, and primary ascites cells express
RT   the human Muellerian inhibiting substance (MIS) type II receptor,
RT   bind, and are responsive to MIS.";
RL   Clin. Cancer Res. 5:3488-3499(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS PMDS2 CYS-54; VAL-142; GLN-282; GLY-426; 444-LEU--GLU-452
RP   DEL; ALA-458; HIS-491 AND CYS-504.
RX   MEDLINE=97026287; PubMed=8872466; DOI=10.1093/hmg/5.9.1269;
RA   Imbeaud S., Belville C., Messika-Zeitoun L., Rey R., di Clemente N.,
RA   Josso N., Picard J.-Y.;
RT   "A 27 base-pair deletion of the anti-Muellerian type II receptor gene
RT   is the most common cause of the persistent Muellerian duct syndrome.";
RL   Hum. Mol. Genet. 5:1269-1277(1996).
RN   [6]
RP   VARIANT PMDS2 GLN-406.
RX   MEDLINE=21434063; PubMed=11549681; DOI=10.1210/jc.86.9.4390;
RA   Messika-Zeitoun L., Gouedard L., Belville C., Dutertre M., Lins L.,
RA   Imbeaud S., Hughes I.A., Picard J.-Y., Josso N., di Clemente N.;
RT   "Autosomal recessive segregation of a truncating mutation of anti-
RT   Muellerian type II receptor in a family affected by the persistent
RT   Muellerian duct syndrome contrasts with its dominant negative activity
RT   in vitro.";
RL   J. Clin. Endocrinol. Metab. 86:4390-4397(2001).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting
CC       of two type II and two type I transmembrane serine/threonine
CC       kinases. Type II receptors phosphorylate and activate type I
CC       receptors which autophosphorylate, then bind and activate SMAD
CC       transcriptional regulators. Receptor for anti-Muellerian hormone.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR: Magnesium or manganese (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DISEASE: Defects in AMHR2 are the cause of persistent Muellerian
CC       duct syndrome type 2 (PMDS2) [MIM:261550]. PMDS2 is a form of male
CC       pseudohermaphroditism characterized by a failure of Muellerian
CC       duct regression in otherwise normal males.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Anti-Mullerian hormone entry;
CC       URL="http://en.wikipedia.org/wiki/Anti-m%C3%BCllerian_hormone";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X89013; CAA61418.1; -; Genomic_DNA.
DR   EMBL; U29700; AAC50328.1; -; Genomic_DNA.
DR   EMBL; X91156; CAA62593.1; -; Genomic_DNA.
DR   EMBL; X91157; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91158; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91159; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91160; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91161; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91162; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91163; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91164; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91165; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91166; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; AF172932; AAD48497.1; -; mRNA.
DR   EMBL; BC126316; AAI26317.1; -; mRNA.
DR   EMBL; BC136356; AAI36357.1; -; mRNA.
DR   IPI; IPI00003446; -.
DR   PIR; JC4335; JC4335.
DR   RefSeq; NP_001158163.1; -.
DR   RefSeq; NP_065434.1; -.
DR   UniGene; Hs.659889; -.
DR   ProteinModelPortal; Q16671; -.
DR   SMR; Q16671; 21-125, 202-510.
DR   STRING; Q16671; -.
DR   PRIDE; Q16671; -.
DR   Ensembl; ENST00000257863; ENSP00000257863; ENSG00000135409.
DR   GeneID; 269; -.
DR   UCSC; uc001scx.1; human.
DR   CTD; 269; -.
DR   GeneCards; GC12P053823; -.
DR   H-InvDB; HIX0201921; -.
DR   HGNC; HGNC:465; AMHR2.
DR   MIM; 261550; phenotype.
DR   MIM; 600956; gene.
DR   Orphanet; 2856; Persistent Mullerian duct syndrome.
DR   PharmGKB; PA24770; -.
DR   eggNOG; prNOG18522; -.
DR   HOGENOM; HBG127407; -.
DR   HOVERGEN; HBG097461; -.
DR   InParanoid; Q16671; -.
DR   OMA; ARLTAEC; -.
DR   OrthoDB; EOG9Z390D; -.
DR   PhylomeDB; Q16671; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BRENDA; 2.7.11.30; 247.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   NextBio; 1057; -.
DR   ArrayExpress; Q16671; -.
DR   Bgee; Q16671; -.
DR   CleanEx; HS_AMHR2; -.
DR   Genevestigator; Q16671; -.
DR   GermOnline; ENSG00000135409; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042562; F:hormone binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005071; F:transmembrane receptor protein serine/threo...; TAS:UniProtKB.
DR   GO; GO:0001880; P:Mullerian duct regression; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR000472; Activin_rcpt.
DR   InterPro; IPR017193; Anti-muellerian_hrmn_rcpt_II.
DR   InterPro; IPR015771; Anti-muellerian_hrmn_rcpt_II_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   PANTHER; PTHR23255:SF4; MIS_II_R; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037392; AMHRII; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Disease mutation; Glycoprotein;
KW   Kinase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Pseudohermaphroditism; Receptor;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     17       Potential.
FT   CHAIN        18    573       Anti-Muellerian hormone type-2 receptor.
FT                                /FTId=PRO_0000024408.
FT   TOPO_DOM     18    149       Extracellular (Potential).
FT   TRANSMEM    150    170       Helical; (Potential).
FT   TOPO_DOM    171    573       Cytoplasmic (Potential).
FT   DOMAIN      203    518       Protein kinase.
FT   NP_BIND     209    217       ATP (By similarity).
FT   ACT_SITE    333    333       Proton acceptor (By similarity).
FT   BINDING     230    230       ATP (By similarity).
FT   CARBOHYD     66     66       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    119    119       N-linked (GlcNAc...) (Potential).
FT   VARIANT      54     54       R -> C (in PMDS2).
FT                                /FTId=VAR_015525.
FT   VARIANT     142    142       G -> V (in PMDS2).
FT                                /FTId=VAR_015526.
FT   VARIANT     282    282       H -> Q (in PMDS2).
FT                                /FTId=VAR_015527.
FT   VARIANT     406    406       R -> Q (in PMDS2).
FT                                /FTId=VAR_015528.
FT   VARIANT     426    426       D -> G (in PMDS2).
FT                                /FTId=VAR_015529.
FT   VARIANT     444    452       Missing (in PMDS2).
FT                                /FTId=VAR_031057.
FT   VARIANT     458    458       V -> A (in PMDS2).
FT                                /FTId=VAR_015530.
FT   VARIANT     491    491       D -> H (in PMDS2).
FT                                /FTId=VAR_015531.
FT   VARIANT     504    504       R -> C (in PMDS2).
FT                                /FTId=VAR_015532.
FT   CONFLICT    161    161       L -> V (in Ref. 2; CAA62593).
SQ   SEQUENCE   573 AA;  62750 MW;  1347C10C2942FDBA CRC64;
     MLGSLGLWAL LPTAVEAPPN RRTCVFFEAP GVRGSTKTLG ELLDTGTELP RAIRCLYSRC
     CFGIWNLTQD RAQVEMQGCR DSDEPGCESL HCDPSPRAHP SPGSTLFTCS CGTDFCNANY
     SHLPPPGSPG TPGSQGPQAA PGESIWMALV LLGLFLLLLL LLGSIILALL QRKNYRVRGE
     PVPEPRPDSG RDWSVELQEL PELCFSQVIR EGGHAVVWAG QLQGKLVAIK AFPPRSVAQF
     QAERALYELP GLQHDHIVRF ITASRGGPGR LLSGPLLVLE LHPKGSLCHY LTQYTSDWGS
     SLRMALSLAQ GLAFLHEERW QNGQYKPGIA HRDLSSQNVL IREDGSCAIG DLGLALVLPG
     LTQPPAWTPT QPQGPAAIME AGTQRYMAPE LLDKTLDLQD WGMALRRADI YSLALLLWEI
     LSRCPDLRPD SSPPPFQLAY EAELGNTPTS DELWALAVQE RRRPYIPSTW RCFATDPDGL
     RELLEDCWDA DPEARLTAEC VQQRLAALAH PQESHPFPES CPRGCPPLCP EDCTSIPAPT
     ILPCRPQRSA CHFSVQQGPC SRNPQPACTL SPV
//
